Release Summary

ALS and AD bioinformatics reports confirm GM6's role as regulator of disease-relevant pathways. Genervon’s drug candidate GM6 modulated 89 ALS-associated genes and 84 AD-associated genes.

Genervon Biopharmaceuticals LLC